Reply to P. de Boissieu et al.

Birtle, Alison; Jones, Robert; Cafferty, Fay H; Biscombe, Katie; Hall, Emma

Birtle, Alison; Jones, Robert; Cafferty, Fay H; Biscombe, Katie; Hall, Emma.

Afiliação

Birtle A; Alison Birtle, MBBS, MRCP, FRCR, MD, Lancashire Teaching Hospitals NHS Foundation Trust, Preston, UK, University of Manchester, Manchester, UK, University of Central Lancashire, Preston, UK; Robert Jones, MBChB, PhD, University of Glasgow, Glasgow, UK, Beatson West of Scotland Cancer Centre, Glasgow
Jones R; Alison Birtle, MBBS, MRCP, FRCR, MD, Lancashire Teaching Hospitals NHS Foundation Trust, Preston, UK, University of Manchester, Manchester, UK, University of Central Lancashire, Preston, UK; Robert Jones, MBChB, PhD, University of Glasgow, Glasgow, UK, Beatson West of Scotland Cancer Centre, Glasgow
Cafferty FH; Alison Birtle, MBBS, MRCP, FRCR, MD, Lancashire Teaching Hospitals NHS Foundation Trust, Preston, UK, University of Manchester, Manchester, UK, University of Central Lancashire, Preston, UK; Robert Jones, MBChB, PhD, University of Glasgow, Glasgow, UK, Beatson West of Scotland Cancer Centre, Glasgow
Biscombe K; Alison Birtle, MBBS, MRCP, FRCR, MD, Lancashire Teaching Hospitals NHS Foundation Trust, Preston, UK, University of Manchester, Manchester, UK, University of Central Lancashire, Preston, UK; Robert Jones, MBChB, PhD, University of Glasgow, Glasgow, UK, Beatson West of Scotland Cancer Centre, Glasgow
Hall E; Alison Birtle, MBBS, MRCP, FRCR, MD, Lancashire Teaching Hospitals NHS Foundation Trust, Preston, UK, University of Manchester, Manchester, UK, University of Central Lancashire, Preston, UK; Robert Jones, MBChB, PhD, University of Glasgow, Glasgow, UK, Beatson West of Scotland Cancer Centre, Glasgow

J Clin Oncol ; 42(24): 2943-2944, 2024 Aug 20.

Article em En | MEDLINE | ID: mdl-38913959